News (Updated October 2, 2011)

[Home]  [
Previous news]


Compulsory HIV testing planned in Kenya – report

26 Sep 2011

By Katy Migiro

wpe5.jpg (13541 bytes)NAIROBI (AlertNet) – Kenya plans to introduce compulsory HIV testing for people seeking treatment for malaria and typhoid and for all children seeking medical treatment, the Daily Nation  newspaper reported on Monday.

Only 60 per cent of Kenyans know their HIV status and the government is keen to boost this figure.

Many people are unwilling to undergo voluntary counselling and testing due to the stigma associated with it, the report said.

“Testing for HIV can have significant benefits,” the newspaper quoted Peter Cherutich, Head of the National AIDS and STI Control Programme, as saying.

“Those who have taken an HIV test and know the result are more likely to have a higher level of education, be in employment, have accurate HIV knowledge, and a higher perception of risk.”

Women account for 65 per cent of new infections in Kenya , with young women aged 15 – 24 four times as likely as young men to become infected, according to some reports.

Compulsory HIV testing is considered a violation of human rights by rights groups

 

Kenya plans to export generic AIDS drugs – report

26 Sep 2011

By Katy Migiro

NAIROBI (AlertNet) – Kenya hopes to become the fourth African country to manufacture and export antiretroviral (ARV) drugs to combat HIV/AIDS, Business Daily newspaper reported on Monday.

Universal Corporation Limited has applied to the World Health Organisation to certify the drug Lamozoid, so that it can be included in the list of drugs approved by the Global Fund to Fight AIDS, Tuberculosis and Malaria.

The Global Fund is the largest multilateral donor to the HIV/AIDS response in developing countries so getting on its list of approved medications is crucial for drugs suppliers.

“Since the funding for these international orders will be from the global kitty, accredited firms enjoy guaranteed payments besides expanding their export markets,” Palu Dhanani, Universal Corporation Limited’s managing director, told the paper.

Kenya has a shortage of ARVs, according to Kenya 's minister for public health and sanitation, Beth Mugo, with only half of those who require the drugs receiving them.

 

Britain lifts ban on gay men giving blood

(AFP) – Sep 8, 2011 

LONDON Britain said Thursday it was lifting a ban on gay men giving blood providing they have had not had homosexual intercourse within a year.

A lifetime ban on blood donation by men who have had sex with another man was introduced in Britain in the 1980s as a response to the spread of AIDS and HIV.

But a review by a panel of leading experts and patient groups found it could no longer support their permanent exclusion.

However, men who have had anal or oral sex with another man in the past 12 months, with or without a condom, will still be barred from donating blood, the Department of Health said.

The experts considered the risk of infection being transmitted through blood, the willingness of potential donors to comply with the selection criteria and improvements in testing donated blood.

The change brings the criteria for men who have had sex with men into line with other groups who are deferred from giving blood for 12 months due to infection risks associated with sexual behaviour.

These include women who have slept with a man who has had sex with another man, people who have slept with prostitutes and those who have had intercourse with anyone who has injected themselves with drugs.

The announcement was welcomed by human rights campaigner Peter Tatchell, but he said it fell short of lifting the ban on gay men who always use condoms.

He said: "Although the new policy is a big improvement on the existing discriminatory rules, a 12-month ban is still excessive and unjustified."

Tatchell, who launched the first campaign against the lifetime ban in 1991, added: "Most gay and bisexual men do not have HIV and will never have HIV.

"If they always have safe sex with a condom, have only one partner and test HIV negative, their blood is safe to donate.

"They can and should be allowed to help save lives by becoming donors."

Copyright © 2011 AFP.

 

Economists say adult circumcision not best anti-HIV tactic

By Oren Dorell, USA TODAY

A group of top world economists said Wednesday that adult male circumcision, a global priority for preventing HIV infection, is not nearly as cost-effective as other methods of prevention.

By Jinty Jackson, AFP/Getty Images

A Swazi man awaits to be circumcised in a massive, nationwide drive to circumcise its men in a bid to curb the spread of HIV.

A successful adult male circumcision effort would require "a large public campaign to get people into the clinic," said Bjorn Lomborg, director of the Copenhagen Consensus Center , a Danish think tank focused on cost-effective public spending that commissioned the panel.

Getting men to volunteer to be circumcised would not be easy and "it could cause more risky behavior," Lomborg said.

The economists conducted a first-ever cost-benefit analysis of the top AIDS-fighting approaches by comparing the costs of prevention and treatment options per lives saved.

The group told representatives of global organizations at Georgetown University that more cost-effective ways to prevent the spread of the disease are an HIV vaccine, infant male circumcision, preventing mother-to-child transmission of the disease and making blood transfusions safe.

Each year 2.5million people are infected with the disease and 2million die, about 70% of them in Africa, according to the Copenhagen center.

Marelize Gorgens, HIV prevention coordinator at the World Bank, disagreed with the economists, saying male circumcision is like a vaccine because it reduces the risk of infection by 60%.

"We need to spend money on things we know work," Gorgens said.

The World Bank and the U.S. State Department support a major push for adult male circumcision. But the economists estimated the cost-benefit ratio for such circumcisions at 23:1. The economists said increasing annual spending on an AIDS vaccine by $100million would be a better investment because it could potentially eradicate the disease, even though the cost-benefit ratio, 12:1, is lower, Lomborg said.

Other improvements "are so cheap and effective" they jumped to the top of the list, he said.

Preventing mother-to-child transmission by treating HIV-positive pregnant women with medication and improving the blood supply had a cost-benefit ratios of 95:1 and 393:1, respectively.

"Making blood transfusions safe costs almost nothing, but we're not doing it," Lomborg said.

 

 


[Home]  [Previous news]